1. R. Zeisler, F. Lux, H. Seidenberger, H. Schönenberger, and W. Beck, “Studies on the distribution of platinum in tumor-bearing rats after the administration of platinum coordination complexes used in cancer chemotherapy.” in:Nuclear Activation Techniques in the Life Sciences 1978. International Atomic Energy Agency, Wien (1979).
2. S. Trebert Haeberlin, F. Lux, J. Karl, T. Spruß, and H. Schönenberger,J. Radioanal. Nucl. Chem., Articles 113, 461 (1987).
3. S. Trebert Haeberlin, F. Lux, T. Spruß, R. Gust, and H. Schönenberger, “Determination of platinum and biologically essential trace elements by neutron activation analysis in pharmacokinetic studies on cisplatin derivatives with estrophilic ligands.” in: M. Nicolini, ed.,Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Martinus Nijhoff Publishing, Boston (1988).
4. R. Müller, R. Gust, M. Jennerwein, H. Reile, R. Laske, W. Krischke, G. Bernhardt, Th. Spruss, J. Engel, and H. Schönenberger,Eur. J. Med. Chem. 24, 341 (1989).
5. H. Reile, G. Bernhardt, M. Koch, H. Schönenberger, M. Hollstein, and F. Lux,Cancer Chemother. Pharmacol. 30, 113 (1992).